SHASQI, INC.
Targeting cancer with click chemistry
San Francisco, United States · Founded 2021 · $1.9M raised
- Headquarters
- San Francisco, California
- Employees
- 1–10
- Founded
- 2021
- Business Model
- B2G
- Total Funding
- $1.9M
- Last Round
- $1.9M GrantApr 2021
- Rounds
- 2
About
Shasqi is a clinical-stage biotech company using click chemistry — the 2022 Nobel Prize-winning technology — to develop targeted cancer therapeutics. Their proprietary CAPAC® platform delivers cancer drugs directly to tumors while minimizing toxicity to healthy tissue. Shasqi is the first company to apply click chemistry in human patients.
Summary
SHASQI, INC. is a Biotech company based in San Francisco, United States, founded in 2021. It has raised $1.9M in total across 2 rounds, most recently a $1.9M Grant round in Apr 2021. Investors include National Cancer Institute.
Funding History
Apr 2021
Sign up to see all 2 rounds
Grant — per-round amounts, valuations, and who invested in each round.
Investors
Similar Companies
China's leading blood products manufacturer
Global contract research organization providing comprehensive drug development and laboratory ser...
IVI-RMA provides fertility treatments and patient-centered reproductive care, combining research,...
Altos Labs combines academic science and industry development to create medicines that restore ce...
inVentiv Health merged with INC Research to form Syneos Health, integrating clinical and commerci...
Specialty pharmaceutical company
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/shasqi-inc"><img src="https://indexed.vc/api/badge/company/shasqi-inc" alt="SHASQI, INC. on Indexed.vc" width="260" height="76" /></a>